A Phase I/II Trial of Reduced Intensity Conditioning and Familial HLA-Mismatched Bone Marrow Transplantation in Children With Non-Malignant Disorders
Other Hematopoietic | Pediatrics
What is the purpose of this trial?
This study is designed to estimate the efficacy and toxicity of familial HLA mismatched bone marrow transplants in patients with non-malignant disease who are less than 21 years of age and could benefit from the procedure.
- Ages21 years and younger
- Trial withWashington University School of Medicine
- Start Date08/13/2021
- End Date04/30/2024
- Last Updated07/11/2022
- Study HIC#2000025196